iShares Health Innovation Active ETF BMED

Medalist Rating as of | See BlackRock Investment Hub

Morningstar’s Analysis BMED

Will BMED outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

iShares Health Innovation Active ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BMED

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 42.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Gilead Sciences Inc

5.68 833,515
Healthcare

Moderna Inc

5.28 774,314
Healthcare

BlackRock Cash Funds Treasury SL Agency

5.25 770,000
Cash and Equivalents

Danaher Corp

5.22 765,919
Healthcare

AbbVie Inc

4.82 706,910
Healthcare

Thermo Fisher Scientific Inc

4.36 639,680
Healthcare

Biogen Inc

3.66 536,748
Healthcare

IQVIA Holdings Inc

3.61 528,940
Healthcare

Mettler-Toledo International Inc

3.56 522,457
Healthcare

Vertex Pharmaceuticals Inc

3.25 477,360
Healthcare

Sponsor Center